Answer: Pregnant or breastfeeding women, children, individuals with uncontrolled cancer, severe liver or kidney disease, or those who cannot be medically monitored should avoid peptide therapy
Take it daily as part of your routine
Step 4: Ongoing Care According to the company, the program includes ongoing support beyond the initial prescription, including check-ins to monitor progress and adjust treatment, plus access to support for questions or concerns
The combination group showed 1.3 kg greater fat mass reduction measured via DEXA scan, though the difference did not reach statistical significance (p=0.08)
Also good to consider: This study was funded by the company who created bremelanotide and a pharmaceutical company who licensed it
Holmes EW, Yong SL, Eiznhamer D, and Keshavarzian A (1998)